Purnell Choppin, pioneering virologist, has died
Purnell Choppin, a physician, virologist, and scientific administrator who performed pioneering research on viruses at The Rockefeller University and later exerted a powerful influence on biomedical research as president of the Howard Hughes Medical Institute, has died at the age of 91.
Convocation 2021 caps a year like no other
For Rockefeller’s class of 2021, it has been a year with both challenges and accomplishments.
Rockefeller leads an international ranking of research impact
According to this year’s CWTS Leiden Ranking of over 1200 universities from 69 countries, Rockefeller has the highest proportion of frequently cited scientific publications.
New Caspary exhibit honors 58 Rockefeller award winners, past and present
Redesigning the exhibit provided an opportunity to consider how to best honor and commemorate Rockefeller award winners. Discussions with university leadership and an ad-hoc faculty committee steered the process and led to a broadening of the criteria for inclusion.
Evolutionary biologist and ornithologist Richard Prum receives the 2021 Lewis Thomas Prize
The author of The Evolution of Beauty was presented with Rockefeller’s science writing award, which honors scientists as inspirational authors.
Immunologist Katharine Hsu is named director of the Tri-Institutional M.D.-Ph.D. program
The joint program between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center will be lead by Hsu, an accomplished physician-scientist who specializes in immunology research and treatment of blood cancers.
Paul Cohen, expert on fat, is promoted to associate professor
Cohen, a physician-scientist exploring obesity and metabolic disease, has conducted groundbreaking research on the complex inner workings of fat tissue.
Immunologist Daniel Mucida promoted to professor
A pioneer in the field of mucosal immunology, Mucida is unlocking the secrets of the digestive system and answering fundamental questions about the origins of human disease.
Mary Jeanne Kreek, pioneer in studies of addiction, has died
Kreek conducted landmark studies that led to the establishment of methadone as a treatment for heroin addiction. Her work not only yielded new treatments for addiction disorders, but also influenced societal attitudes toward them. She was 84.
Paula Volent is named chief investment officer
The university has named its next vice president and chief investment officer. Volent, who for decades oversaw investments at Bowdoin College, will assume stewardship of Rockefeller's endowment in August.
